Jul 5, 2023 · For example, the Pacific Biosciences of California, Inc. (NASDAQ:PACB) share price has soared 245% in the last half decade. Most would be very happy with that. Most would be very happy with that. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.MENLO PARK, Calif. and SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high ...Sep 8, 2023 · Institutional investors have sold a total of 58,162,176 shares in the last 24 months. This volume of shares sold represents approximately $597.75M in transactions. This page (NASDAQ:PACB) was last updated on 9/10/2023 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Sep 8, 2023 · The average twelve-month price prediction for Pacific Biosciences of California is $13.89 with a high price target of $17.00 and a low price target of $12.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors? Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced its earnings results on Wednesday, August, 2nd. The biotechnology company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.32) by $0.06. The biotechnology company earned $47.57 million during the quarter, compared to analyst estimates of $40.12 million.We would like to show you a description here but the site won’t allow us.Tower Research Capital LLC TRC raised its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 1,892.5% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 37,379 shares of the biotechnologyAbout Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. MENLO PARK, Calif. and SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high ...As with many other companies Pacific Biosciences of California, Inc. (NASDAQ:PACB) makes use of debt. But the real question is whether this debt is making the company risky.Seven Eight Capital LP purchased a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 68,551 shares of the biotechnology company's stock, valued at approximatelyJul 5, 2023 · For example, the Pacific Biosciences of California, Inc. (NASDAQ:PACB) share price has soared 245% in the last half decade. Most would be very happy with that. Most would be very happy with that. Pacific Biosciences of California Inc. (NASDAQ:PACB)’s beta value is holding at 1.67, while the average true range (ATR) indicator is currently reading 0.57. Considering analysts have assigned the stock a price target range of $13.00-$19.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be ...About Key Executives Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as...View Our Latest Analysis on PACB Institutional Investors Weigh In On Pacific Biosciences of California. Pacific Biosciences of California Stock Performance. Shares of NASDAQ:PACB opened at $10.71 on Thursday. Pacific Biosciences of California has a one year low of $4.97 and a one year high of $14.55.Feb 2, 2021 · NASDAQ: PACB Pacific Biosciences Of California. Market Cap. $3B. Today's Change (3.66%) $0.38. Current Price. ... Pacific Biosciences of California (PACB 3.66%), or PacBio, has been viewed as more ... Jun 14, 2023 · On May 2, Pacific Biosciences of California, Inc. (NASDAQ:PACB) reported a Q1 GAAP EPS of -$0.36, falling short of Wall Street estimates by $0.03. The revenue of $38.9 million increased 17.3% year ... Sep 8, 2023 · Christian O. Henry. https://www.pacb.com. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow ... Aug 30, 2023 · Pacific Biosciences of California Inc. (NASDAQ:PACB)’s beta value is holding at 1.67, while the average true range (ATR) indicator is currently reading 0.57. Considering analysts have assigned the stock a price target range of $13.00-$19.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be ... View Our Latest Analysis on PACB Institutional Investors Weigh In On Pacific Biosciences of California. Pacific Biosciences of California Stock Performance. Shares of NASDAQ:PACB opened at $10.71 on Thursday. Pacific Biosciences of California has a one year low of $4.97 and a one year high of $14.55.Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.Sep 7, 2023 · PacBio (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve ... ascension my chart
Pacific Biosciences of California Inc. (NASDAQ:PACB) trade information. Pacific Biosciences of California Inc. (PACB) registered a -0.27% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.27% in intraday trading to $11.10 this Wednesday, 09/06/23, hitting a weekly high.Pacific Biosciences of California Inc. (NASDAQ:PACB)’s beta value is holding at 1.67, while the average true range (ATR) indicator is currently reading 0.57. Considering analysts have assigned the stock a price target range of $13.00-$19.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be ...Aug 6, 2023 · Pacific Biosciences of California (NASDAQ:PACB - Get Free Report) last released its earnings results on Wednesday, August 2nd. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.06. Sep 8, 2023 · The list of insiders at Pacific Biosciences of California includes Christian O Henry, Eric Schaefer, Kathy Ordonez, Lucy Shapiro, Michael Hunkapiller, Michele Farmer, Oene Mark Van, Peter Fromen, Susan G Kim, and William W Ericson. Learn more on insiders at PACB. September 11, 2023. Company. Pacific Biosciences of California Inc. (NASDAQ:PACB) has a beta value of 1.65 and has seen 3.48 million shares traded in the last trading session. The company, currently valued at $2.72B, closed the last trade at $10.39 per share which meant it lost -$0.47 on the day or -4.33% during that session.Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, is well-poised for growth in the coming quarters, courtesy of its slew of strategic deals over the past few months.A robust ...Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced its earnings results on Wednesday, August, 2nd. The biotechnology company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.32) by $0.06. The biotechnology company earned $47.57 million during the quarter, compared to analyst estimates of $40.12 million.Pacific Biosciences of California (NASDAQ:PACB - Get Free Report) last released its earnings results on Wednesday, August 2nd. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.06.Over the past 3 months, 6 analysts have published their opinion on Pacific Biosciences (NASDAQ:PACB) stock. These analysts are typically employed by large Wall Street banks and tasked with ...Pacific Biosciences Stock (NASDAQ:PACB), Short Interest Report. Short interest for Pacific Biosciences gives investors a sense of the degree to which investors are betting on the decline of ...the intelligent investor pdf
Jan 26, 2023 · Then look at the Pacific Biosciences of California, Inc. (NASDAQ:PACB) share price. It's 313% higher than it was five years ago. It's 313% higher than it was five years ago. About Key Executives Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as...Oct 19, 2022 · PacBio (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve ... Pacific Biosciences of California saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 31,390,000 shares, an increase of 10.6% from the previous total of 28,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment.Jul 20, 2021 · More specifically, ARK Investment Management was the largest shareholder of Pacific Biosciences of California, Inc. (NASDAQ:PACB), with a stake worth $709.5 million reported as of the end of March. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero ...Pacific Biosciences of California Inc. (NASDAQ:PACB) trade information. Pacific Biosciences of California Inc. (PACB) registered a -0.27% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.27% in intraday trading to $11.10 this Wednesday, 09/06/23, hitting a weekly high.Oct 20, 2022 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ... Pacific Biosciences of California Inc. (NASDAQ:PACB) trade information. Pacific Biosciences of California Inc. (PACB) registered a -0.27% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.27% in intraday trading to $11.10 this Wednesday, 09/06/23, hitting a weekly high.national rental cars
Aug 6, 2023 · Pacific Biosciences of California (NASDAQ:PACB - Get Free Report) last released its earnings results on Wednesday, August 2nd. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.06. Barclays PLC increased its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 22.2% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 155,179 shares of the biotechnology company's stockPACB. 10.39. -4.33%. Webull offers kinds of Pacific Biosciences of California Inc stock information, including NASDAQ:PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions.Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s share price traded up 3.4% during mid-day trading on Wednesday .The stock traded as high as $11.15 and last traded at ...Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero ... Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Aug 30, 2023 · Pacific Biosciences of California Inc. (NASDAQ:PACB)’s beta value is holding at 1.67, while the average true range (ATR) indicator is currently reading 0.57. Considering analysts have assigned the stock a price target range of $13.00-$19.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be ... Pacific Biosciences shares also spiked in 2020 and into 2021, but they're down by around 49% since reaching a peak this February. Analysts on Wall Street who follow this pioneer of long-read DNA ...PacBio (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve ...The public float for PACB is 246.26M, and at present, short sellers hold a 12.75% of that float. The average trading volume of PACB on September 06, 2023 was 3.63M shares. PACB) stock’s latest price update. Pacific Biosciences of California Inc. (NASDAQ: PACB)’s stock price has decreased by -2.45 compared to its previous closing price of 11.41.Sep 7, 2023 · NASDAQ PACB opened at $11.10 on Thursday. Pacific Biosciences of California, Inc. has a twelve month low of $4.97 and a twelve month high of $14.55. The stock has a 50-day moving average of $12.18 and a 200 day moving average of $11.51. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of -8.21 and a beta of 1.65. Pacific Biosciences of California Inc. (NASDAQ:PACB) shares, rose in value on Friday, September 08, with the stock price down by -1.75% to the previous day’s close as strong demand from buyers drove the stock to $10.67. Actively observing the price movement in the last trading, the stock closed thAdditionally, ILMN must also pay a total of $52M in "continuation advances" to PACB as they were funding PACB operations during the merger period. $34M of that $52M was paid in early 2020.Pacific Biosciences of California PACB shares ended the last trading session 8.9% higher at $11.72. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...The average twelve-month price prediction for Pacific Biosciences of California is $13.89 with a high price target of $17.00 and a low price target of $12.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors?NASDAQ: PACB Show Full Chart Market Closed Aug 25, 2023 4:00 PM EDT | Currency in USD Overview Key Ratios Trading Information Last Close 9.92 Sector Healthcare Industry Medical Devices Investment...Oct 20, 2022 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ... executive airport hotel
Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced its earnings results on Wednesday, August, 2nd. The biotechnology company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.32) by $0.06. The biotechnology company earned $47.57 million during the quarter, compared to analyst estimates of $40.12 million.MENLO PARK, Calif., Nov. 7, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2022. Revenue of $32.3 million, a 7% decrease compared ...Institutional investors have sold a total of 58,162,176 shares in the last 24 months. This volume of shares sold represents approximately $597.75M in transactions. This page (NASDAQ:PACB) was last updated on 9/10/2023 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free.MENLO PARK, Calif. and SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high ...Sep 14, 2023 · Capital Impact Advisors LLC boosted its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 79.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,575 shares of the biotechnolo (NASDAQ: PACB) Pacific Biosciences Of California currently has 250,558,293 outstanding shares. With Pacific Biosciences Of California stock trading at $10.38 per share, the total value of Pacific Biosciences Of California stock (market capitalization) is $2.60B.Find the latest dividend history for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.Barclays PLC increased its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 22.2% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 155,179 shares of the biotechnology company's stockData is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ... Sep 14, 2023 · Capital Impact Advisors LLC boosted its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 79.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,575 shares of the biotechnolo Oct 27, 2010 · MENLO PARK, Calif., Oct 26, 2010 (BUSINESS WIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), developer of single molecule, real-time (SMRT(TM)) technology for biological analysis, announced today the pricing of its initial public offering of 12,500,000 shares of its common stock at $16.00 per share. All shares are being Dec 5, 2022 · On November 16, Canaccord analyst Kyle Mikson maintained a Buy rating on Pacific Biosciences of California, Inc. (NASDAQ:PACB) stock and raised the price target to $14 from $12, noting that the ... PacBio also closes $300 million PIPE financing in support of transaction. MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific ...The average twelve-month price prediction for Pacific Biosciences of California is $13.89 with a high price target of $17.00 and a low price target of $12.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors?Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 10.66 -0.20 (-1.84%) As of 10:30AM EDT. Market open. 1d. atlantic division nhlSep 8, 2023 · The average twelve-month price prediction for Pacific Biosciences of California is $13.89 with a high price target of $17.00 and a low price target of $12.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors? Sep 8, 2023 · Pacific Biosciences of California Inc. (NASDAQ:PACB) shares, rose in value on Friday, September 08, with the stock price down by -1.75% to the previous day’s close as strong demand from buyers drove the stock to $10.67. Actively observing the price movement in the last trading, the stock closed th The data shows that as of Aug 14, 2023 short interest in Pacific Biosciences of California Inc. (PACB) stood at 12.53% of shares outstanding, with shares short rising to 30.71 million registered in Jul 13, 2023. Current price change has pushed the stock 39.49% YTD, which shows the potential for further growth is there.Dec 5, 2022 · On November 16, Canaccord analyst Kyle Mikson maintained a Buy rating on Pacific Biosciences of California, Inc. (NASDAQ:PACB) stock and raised the price target to $14 from $12, noting that the ... PACB. 10.39. -4.33%. Webull offers kinds of Pacific Biosciences of California Inc stock information, including NASDAQ:PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions.Find the latest Institutional Holdings data for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.Pacific Biosciences of California Inc (PACB) Stock Price & News - Google Finance. Markets. US. Dow Jones. +0.14%. +0.092%. 1,851.54. Home PACB • NASDAQ. The public float for PACB is 246.26M, and at present, short sellers hold a 12.75% of that float. The average trading volume of PACB on September 06, 2023 was 3.63M shares. PACB) stock’s latest price update. Pacific Biosciences of California Inc. (NASDAQ: PACB)’s stock price has decreased by -2.45 compared to its previous closing price of 11.41.Sep 11, 2023 · Company. Pacific Biosciences of California Inc. (NASDAQ:PACB) has a beta value of 1.65 and has seen 3.48 million shares traded in the last trading session. The company, currently valued at $2.72B, closed the last trade at $10.39 per share which meant it lost -$0.47 on the day or -4.33% during that session. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... 9:44a Nasdaq leads stock market ...Find the latest SEC Filings data for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.(NASDAQ: PACB) Pacific Biosciences Of California currently has 250,558,293 outstanding shares. With Pacific Biosciences Of California stock trading at $10.38 per share, the total value of Pacific Biosciences Of California stock (market capitalization) is $2.60B.PACB setting up nicely PACB is continuing to make higher highs and higher lows. 50 MA acting as resistance. A clean break above the 50 will be my entry point. Looking for PACB to make an explosive move as we get closer to the apex of the triangle. PT $35-$38 in 4-5 weeks. Using trendline as stop loss.Pacific Biosciences of California Inc. (NASDAQ:PACB) traded at $10.50 at last check on Wednesday, August 23, made an upward move of 2.23% on its previous day’s price. Looking at the stock we see that its previous close was $10.27 and the beta (5Y monthly) reads 1.65 with the day’s price range being $10.035 – $10.53.Sep 6, 2023 · The public float for PACB is 246.26M, and at present, short sellers hold a 12.75% of that float. The average trading volume of PACB on September 06, 2023 was 3.63M shares. PACB) stock’s latest price update. Pacific Biosciences of California Inc. (NASDAQ: PACB)’s stock price has decreased by -2.45 compared to its previous closing price of 11.41. zip codes for bay area
Find the latest Financials data for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.Find the latest analyst research for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. ... Based on analysts offering 12 month price targets for PACB in the last 3 months. Pacific Biosciences of California, Inc. Common Stock (PACB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Find the latest analyst research for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. ... Based on analysts offering 12 month price targets for PACB in the last 3 months.Sep 2, 2023 · The data shows that as of Aug 14, 2023 short interest in Pacific Biosciences of California Inc. (PACB) stood at 12.53% of shares outstanding, with shares short rising to 30.71 million registered in Jul 13, 2023. Current price change has pushed the stock 39.49% YTD, which shows the potential for further growth is there. Sep 11, 2023 · Company. Pacific Biosciences of California Inc. (NASDAQ:PACB) has a beta value of 1.65 and has seen 3.48 million shares traded in the last trading session. The company, currently valued at $2.72B, closed the last trade at $10.39 per share which meant it lost -$0.47 on the day or -4.33% during that session. Prime Capital Investment Advisors LLC purchased a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 21,033 shares of the biotechnology company's stock, valued at approximately $244,000.On November 16, Canaccord analyst Kyle Mikson maintained a Buy rating on Pacific Biosciences of California, Inc. (NASDAQ:PACB) stock and raised the price target to $14 from $12, noting that the ...Jun 14, 2023 · Pacific Biosciences of California (NASDAQ:PACB) $3.3 billion Champion of DNA long-read sequencing technology. Exact Sciences (NASDAQ:EXAS) $16.8 billion Sep 7, 2023 · NASDAQ PACB opened at $11.10 on Thursday. Pacific Biosciences of California, Inc. has a twelve month low of $4.97 and a twelve month high of $14.55. The stock has a 50-day moving average of $12.18 and a 200 day moving average of $11.51. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of -8.21 and a beta of 1.65. ameritas life insurance
MENLO PARK, Calif. , Jan. 13, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today celebrated long-read sequencing being named Nature Methods’ “Method of the Year 2022.”. Nature Methods had recognized the impact of long-read sequencing in a variety of groundbreaking ...Get the latest Pacific Biosciences of California Inc (PACB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...Dec 15, 2020 · Additionally, ILMN must also pay a total of $52M in "continuation advances" to PACB as they were funding PACB operations during the merger period. $34M of that $52M was paid in early 2020. On May 2, Pacific Biosciences of California, Inc. (NASDAQ:PACB) reported a Q1 GAAP EPS of -$0.36, falling short of Wall Street estimates by $0.03. The revenue of $38.9 million increased 17.3% year ...Find the latest dividend history for Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.